论文部分内容阅读
目的探讨奥曲肽联合凝血酶治疗肝硬化合并上消化道出血的疗效。方法选取本院2014年7月-2016年7月期间收治的62例肝硬化合并上消化道出血患者,依据随机法划分为参照组与研究组各31例。参照组31例患者给予奥曲肽为主的常规治疗,研究组31例患者给予奥曲肽联合凝血酶治疗。对两组患者临床指标及临床治疗效果进行比较。结果研究组临床指标均显著低于参照组(P<0.05);研究组治疗有效率显著高于参照组(P<0.05)。结论对肝硬化合并上消化道出血患者应用奥曲肽联合凝血酶治疗可取得非常明显的治疗效果,其效果优于奥曲肽治疗,值得推广。
Objective To investigate the efficacy of octreotide combined with thrombin in the treatment of cirrhosis and upper gastrointestinal bleeding. Methods Sixty-two patients with cirrhosis complicated with upper gastrointestinal bleeding who were treated in our hospital from July 2014 to July 2016 were selected and divided into the reference group and the study group according to the randomized method. Reference group of 31 patients given octreotide-based conventional therapy, 31 patients in the study group were given octreotide combined thrombin therapy. The clinical indicators of two groups of patients and clinical treatment were compared. Results The clinical indexes in the study group were significantly lower than those in the reference group (P <0.05). The treatment efficiency in the study group was significantly higher than that in the reference group (P <0.05). Conclusions The application of octreotide combined with thrombin in patients with cirrhosis and upper gastrointestinal bleeding can achieve a very significant therapeutic effect, which is superior to octreotide treatment and worthy of promotion.